The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2479174
WO Application Number:
CN2010001293
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10814867.7
WO Publication Number:
WO2011029265
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
China (CN)
Publications:
Dates
Filing date:
26/08/2010
Grant date:
18/10/2017
EP Publication Date:
25/07/2012
WO Publication Date:
17/03/2011
Claims Translations Received Date:
Claims Translation B1 Received Date:
05/01/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
18/10/2017
EP B1 Publication Date:
18/10/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
25/08/2030
Lapsed By Expiration Date:
Patent Validated Date:
17/01/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
18/10/2017
Name:
Jiangsu Hengrui Medicine Co., Ltd.
Address:
No. 145 Renmin East Road Xinpu District, LIANYUNGANG, JIANGSU 222002, China (CN)
From:
18/10/2017
Name:
Shanghai Hengrui Pharmaceutical Co. Ltd.
Address:
279 Wenjing Road, MINHANG DISTRICT SHANGHAI 200245, China (CN)
Agent
Name:
ir. H.A. Witmans c.s.
From:
16/01/2018
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)